Market Overview
The global barbituric acid market was valued at USD 20 million in 2024. The market is projected to grow from USD 21 million in 2025 to USD 27.8 million by 2031, exhibiting a CAGR of 5.0% during the forecast period.
USD 20 million in 2024
2032 USD 27.8 million by 2031
of 5.0%
Pharmaceutical Grade Barbituric Acid
Industrial Grade Barbituric Acid
Pharmaceutical Grade Barbituric Acid represents the leading segment, driven by its critical role as the foundational precursor for barbiturate drugs, which are essential in specific therapeutic areas like anesthesia and seizure control despite broader market shifts. The stringent purity requirements for pharmaceutical applications create a high barrier to entry and ensure consistent demand from established drug manufacturers. This segment's growth is supported by ongoing research into new applications for barbiturate-derived compounds.
By Application
VB2 (Riboflavin) Synthesis
Barbiturate Drugs
Dye Intermediates
Others
Barbiturate Drugs is the dominant application segment, as barbituric acid is the essential chemical skeleton for this class of pharmaceutical compounds. While the therapeutic use of barbiturates has declined in some areas due to safety profiles, they remain vital in specific medical fields, maintaining a steady demand base. The VB2 Synthesis application is also significant, with barbituric acid serving as a key intermediate in the production of vitamin B2, a necessary nutrient for human and animal health, linking demand to the stability of the food and feed additive industries.
Our Key Players
Zhengzhou Lifeng Chemical
Hebei Chengxin
Zhejiang Kanglong Pharmaceutical
Hangzhou Hyper Chemicals
Nantong Acetic Acid Chemical
Shanghai Worldyang Chemical
